When patent protection expired in November for Pfizer Inc.'s Lipitor (atorvastatin), many mourned its passing as the end of the golden age of mega blockbusters. Read More
Amgen Inc. and AstraZeneca plc's recent five-product inflammation partnership makes them the latest players in the peer-to-peer collaboration game, a business development trend that appears to be gaining traction now that the patent cliff is at hand. Read More
Inhaled asthma and chronic obstructive pulmonary disease (COPD) drugs act at the lung to improve breathing, but at supraoptimal doses, the drugs end up elsewhere in the body, potentially leading to undesirable side effects. Read More
